Compare First Citizens BancShares Inc (FCNCA) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
First Citizens BancShares Inc vs Revvity Inc — how do they compare? First Citizens BancShares Inc trades at $2,068.39 (market cap $22.94B), while Revvity Inc trades at $154.18 (market cap $16.98B). The key difference: First Citizens BancShares Inc is the larger of the two by market cap, and First Citizens BancShares Inc pays the higher dividend (0.41%). Which is the better fit depends on your goals — on Pluang, investors hold First Citizens BancShares Inc for 29 Days and Revvity Inc for 12 Days on average.
| FCNCA | RVTY | |
|---|---|---|
Market Cap | $22.94B | $16.98B |
Volume | 91,668 | 1,456,900 |
Sector | Sector/Thematic | Health |
52-Week High | $2.29K | $157.36 |
52-Week Low | $1.64K | $82.26 |
Typical Hold Time | 29 Days | 12 Days |
Dividend Yield | 0.41% | 0.18% |
Enterprise Value | — | $19.30B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
First Citizens BancShares (FCNCA) trades at $2,065.89, down 0.27% on the day, with a bearish technical signal driven by moving averages. The stock shows strong fundamentals, with a P/E of 11.08 and net income margin of 25.23%, while recent earnings beats in Q1 and Q2 2026 highlight operational strength. Recent news includes a $157 million financing deal and a branch expansion, supporting growth initiatives.
The outlook remains positive given solid profitability and analyst consensus leaning toward hold with a $2,290 price target. Key risks include market volatility and execution of expansion strategies, but institutional accumulation and earnings momentum provide a stable foundation for investors.
RVTY trades at $152.16, down 0.94% today, near its recent 52-week high of $158.28 (Defense World, 2026-10-01). The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for three consecutive quarters. Recent positive developments include a Zacks upgrade to Buy (2026-10-02) and the launch of a new Type 1 diabetes screening kit in Europe (Business Wire, 2026-09-24).
The outlook is positive, supported by earnings momentum and strategic expansions, but the stock's premium valuation (P/E of 73.15) and margin pressures pose risks. Analyst consensus is bullish with a $132.13 price target, though the current price exceeds it, suggesting near-term consolidation may occur before further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About First Citizens BancShares Inc
First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.
Read more on FCNCA →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
